GleamWall
中文EN

NEPH NEPHROS INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1196298 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.4%
TTM net income YoY29.0%
TTM EPS YoY28.6%
Revenue 3-yr CAGR16.8%
Net income 3-yr CAGR—

Margins

Gross margin60.5%
Operating margin8.5%
Net margin8.9%
FCF margin—
EBITDA margin9.0%

Returns

ROE16.9%
ROA13.4%
ROIC (approx.)22.5%
Asset turnover1.51x

Leverage & solvency

Liabilities / assets18.0%
Debt / equity0.00x
Current ratio5.50x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.48x
Accruals ratio19.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$5.62M$6.02M$5.21M$4.73M$4.76M$4.42M$4.88M$3.87M
Cost of revenue$2.34M$1.99M$2.22M$1.97M$1.85M$1.62M$1.72M$1.40M
Gross profit$3.29M$4.03M$2.99M$2.76M$2.92M$2.79M$3.15M$2.48M
R&D expense$331,000$366,000$346,000$395,000$338,000$311,000$295,000$252,000
SG&A expense$2.42M$2.42M$2.52M$2.32M$2.23M$2.20M$2.25M$1.87M
Operating income$501,000$1.21M$97,000$18,000$314,000$248,000$566,000$317,000
Interest expense$0$1,000—$0$0$1,000—$0
Pretax income$512,000$1.21M—$62,000$340,000$246,000—$364,000
Income tax$0$13,000$0$0$3,000$9,000$0$15,000
Net income$512,000$1.20M$140,000$62,000$337,000$237,000$558,000$349,000
EBITDA$530,000$1.24M$126,000$50,000$348,000$283,000$605,000$351,000
EPS (basic)0.050.110.01—0.030.020.05—
EPS (diluted)0.050.110.01—0.030.020.05—
Weighted avg. shares (diluted)11.20M11.11M10.99M—11.04M10.81M10.62M—
Balance sheet
Cash & equivalents$4.55M$4.70M$4.02M$5.40M$5.17M$5.07M$4.08M$3.76M
Receivables$3.58M$4.10M$3.52M$2.41M$2.66M$2.04M$2.68M$1.78M
Inventory$4.95M$4.55M$3.62M$3.23M$2.74M$2.24M$1.95M$2.62M
Current assets$13.26M$13.60M$11.50M$11.22M$10.71M$9.58M$8.99M$8.30M
PP&E, net$72,000$83,000$95,000$106,000$119,000$131,000$143,000$161,000
Goodwill$759,000$759,000$759,000$759,000$759,000$759,000$759,000$759,000
Intangibles$294,000$302,000$310,000$318,000$326,000$334,000$341,000$349,000
Total assets$15.30M$15.77M$13.79M$13.64M$13.25M$12.24M$11.78M$11.21M
Current liabilities$2.41M$3.34M$2.53M$2.77M$2.47M$1.77M$1.52M$1.56M
Total liabilities$2.76M$3.80M$3.09M$3.44M$3.24M$2.64M$2.49M$2.62M
Shareholders' equity$12.55M$11.97M$10.70M$10.20M$10.01M$9.60M$9.29M$8.59M
Shares outstanding10.87M10.86M10.84M10.64M10.63M10.60M10.60M10.54M
Cash flow statement
Operating cash flow-$150,000$681,000-$1.67M$230,000$99,000$994,000$322,000$1.30M
Capital expenditure———————$0
Free cash flow———————$1.30M
Investing cash flow———————$0
Financing cash flow-$1,000-$2,000$289,000-$1,000-$2,000-$1,000-$1,000-$1,000
Depreciation & amortization$29,000$29,000$29,000$32,000$34,000$35,000$39,000$34,000
Stock-based compensation$60,000$61,000$60,000$79,000$70,000$71,000$76,000$62,000

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.